Analysis of NGF pathway proteins in matched CSF/plasma samples from DSAD and individuals with DS aDS, as well as controls, revealed that the levels of the 50 kDa isoform of proNGF and MMP9 in CSF were competent to identify symptomatic AD from the wider DS population. The gene discussed is MMP9; the disease is Alzheimer disease.